ARCHIVES

Levamisole/5-FU Could Save $226 Mil. If Fully Adopted, NCI Economist Says

This article is from The Cancer Letter archive.

Vol. 16 No. 16 | April 20, 1990

Download PDF Visit The Full Archive

Related Articles

NABCO to close June 30.

January 30, 2004

Clinical Trials: NCI Forms Panel To Help Implement Recommendations

December 12, 1997

In Vote Against Tarceva As Maintenance, ODAC Seeks Stronger Survival Benefit

December 18, 2009

Michelle Le Beau named director of University of Chicago Cancer Research Center.

May 7, 2004

Give New Investigators “Special Consideration,” Advisors Tell NCI

June 28, 2002

Cancer Groups Urge FDA To Spell Out Standards For Data Collection In Time-To-Progression Trials.

November 7, 2008